We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Generic products

News List

South Africa’s Aspen Pharmacare boosts Africa’s healthcare distribution market with new deals Shem Oirere
November 16, 2023
Aspen Pharmacare Holdings Ltd continues to scale up medical distribution deals with international drug manufacturers as it seeks to increase its share of the healthcare distribution market in South Africa and rest of Sub-Saharan Africa.
Over 158 applications for generic products pending with US FDA for approval: Lupin expresspharma
July 22, 2020
Sharing information with company's shareholders, Lupin MD Nilesh Gupta and CEO Vinita Gupta said the company's US business stabilised last fiscal and saw an increase of 5 per cent on the back of products like Levothyroxine and Oseltamivir.
Sun Pharma to develop more generic products in China biospectrumasia
August 18, 2019
Indian pharma major Sun Pharmaceutical Industries Ltd. has announced that one of its wholly owned subsidiaries has granted an exclusive license to a subsidiary of China Medical System Holdings Ltd.
Lupin aims to launch around 30 generic products in the US financialexpress
June 29, 2018
With rapid approvals from US health regulator anticipated, homegrown drug major Lupin sees opportunity to launch around 30 generic products in the world’s largest pharmaceuticals market this year, according to a top company official.